These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38058036)

  • 1. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation].
    Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
    [No Abstract]   [Full Text] [Related]  

  • 2. Metanephric Adenoma-Epithelial Wilms Tumor Overlap Lesions: An Analysis of BRAF Status.
    Wobker SE; Matoso A; Pratilas CA; Mangray S; Zheng G; Lin MT; Debeljak M; Epstein JI; Argani P
    Am J Surg Pathol; 2019 Sep; 43(9):1157-1169. PubMed ID: 31192863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular features of metanephric adenoma and their values in differential diagnosis].
    Wang X; Shi SS; Yang WR; Ye SB; Li R; Ma HH; Zhang RS; Lu ZF; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):38-42. PubMed ID: 28072975
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis.
    Pan CC; Tseng CE; Kuroda N; Yano M; Yasuda M; Nagashima Y; Yeh YC; Wang YC; Chang YH; Epstein JI
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):257-263. PubMed ID: 35384875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical metanephric adenoma: Shares similar histopathological features and molecular changes of metanephric adenoma and epithelial-predominant Wilms' tumor.
    Yin X; Zhang X; Pan X; Tan J; Zheng L; Zhou Q; Chen N
    Front Oncol; 2022; 12():1020456. PubMed ID: 36313688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.
    Catic A; Kurtovic-Kozaric A; Sophian A; Mazur L; Skenderi F; Hes O; Rohan S; Rakheja D; Kogan J; Pins MR
    BMC Med Genet; 2020 Oct; 21(1):202. PubMed ID: 33046021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma.
    Udager AM; Pan J; Magers MJ; Palapattu GS; Morgan TM; Montgomery JS; Weizer AZ; Hafez KS; Miller DC; Wolf JS; McHugh JB; Chinnaiyan AM; Dhanasekaran SM; Mehra R
    Am J Surg Pathol; 2015 Apr; 39(4):549-57. PubMed ID: 25602792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
    Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF mutations in metanephric adenoma of the kidney.
    Choueiri TK; Cheville J; Palescandolo E; Fay AP; Kantoff PW; Atkins MB; McKenney JK; Brown V; Lampron ME; Zhou M; Hirsch MS; Signoretti S
    Eur Urol; 2012 Nov; 62(5):917-22. PubMed ID: 22727996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution.
    Chan E; Stohr BA; Croom NA; Cho SJ; Garg K; Troxell ML; Higgins JP; Bean GR
    Histopathology; 2020 Jun; 76(7):1084-1090. PubMed ID: 32064677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric metanephric tumours: a clinicopathological and molecular characterisation.
    de Jel DVC; Hol JA; Ooms AHAG; de Krijger RR; Jongmans MCJ; Littooij AS; Drost J; van Grotel M; van den Heuvel-Eibrink MM
    Crit Rev Oncol Hematol; 2020 Jun; 150():102970. PubMed ID: 32371339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
    Muir TE; Cheville JC; Lager DJ
    Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition.
    Obasaju P; Shahab S; Dunn E; Rhee DS; Jiang L; Dome JS; Friedman AD; Argani P; Pratilas CA
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF mutations in pediatric metanephric tumors.
    Chami R; Yin M; Marrano P; Teerapakpinyo C; Shuangshoti S; Thorner PS
    Hum Pathol; 2015 Aug; 46(8):1153-61. PubMed ID: 26014474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
    Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
    Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.
    Day F; Muranyi A; Singh S; Shanmugam K; Williams D; Byrne D; Pham K; Palmieri M; Tie J; Grogan T; Gibbs P; Sieber O; Waring P; Desai J
    Target Oncol; 2015 Mar; 10(1):99-109. PubMed ID: 24859797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
    Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
    Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic-Based Immunohistochemistry Combined With Next-Generation Sequencing on Diagnostic Tissue Sections for Detection of Tumoral BRAF V600E Mutation.
    Leblond AL; Rechsteiner M; Jones A; Brajkovic S; Dupouy D; Soltermann A
    Am J Clin Pathol; 2019 Jun; 152(1):59-73. PubMed ID: 31065676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors.
    Marsden L; Jennings LJ; Gadd S; Yu M; Perlman EJ; Cajaiba MM
    Hum Pathol; 2017 Feb; 60():32-36. PubMed ID: 27769870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.